LOS ANGELES
,
Aug. 30, 2024
/PRNewswire/ — Glancy Prongay & Murray LLP (“GPM”) announces that investors with substantial losses have an opportunity to lead the securities
fraud class action lawsuit against Lifecore Biomedical, Inc. (“Lifecore” or the “Company”) LFCR.
Class Period: October 7, 2020 – March 19, 2024
Lead Plaintiff Deadline: September 27, 2024
If you wish to serve as lead plaintiff of the Lifecore lawsuit, you can submit your contact information. You can also contact Charles H. Linehan, of GPM to learn more about your rights.
The complaint filed during the Class Period alleges that Lifecore failed to disclose to investors crucial information regarding its financial reporting, leading to inaccurate financial statements and compliance issues with NASDAQ listing requirements.
To participate in the class action, you may retain counsel of your choice or take no action at this time. In case of any inquiries, please contact Charles Linehan, Esquire, of GPM.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com
View original content to download multimedia:Read More
SOURCE Glancy Prongay & Murray LLP